Matrix remodeling, degradation, inflammation and invasion liberate peptide fragments that can subsequently interact with cells in an attachment-independent manner. Such 'soluble' matrix components, including collagens, fibronectin and laminin, induced Smad activation (termed crosstalk signaling), which follows a similar chronological sequence and R-Smad specificity as induced by transforming growth factor (TGF)-b1. Smad4 nuclear translocation occurred in response to collagen binding, indicating downstream signal propagation. TGF-b scavenging antibody affected only TGF-b1, but not crosstalk-induced responses. TGF-b type II receptor mutation (DR26D25), which is deficient in TGF-b type I receptor recruitment to the ligand, induced a heterotetramer signaling complex, and propagated Smad2 activation only through collagen induction and not TGF-b signaling. Consequentially, TGF-b ligand participation is not required for crosstalk signaling. This signaling requires a functional integrin b1 receptor as showed by RNA interference. Co-immunoprecipitation (co-IP) and fluorescent microscopy indicate the involvement of focal adhesion kinase (FAK) and Src activity in collagen-induced signal propagation, and suggest a membrane signaling complex formation that includes both TGF-b receptors and integrins. The related gene expressional responses are distinct from that evoked by TGF-b1, supporting its separate function. This signaling mechanism expands and partially explains TGFb receptor dynamics and consequential signaling diversityrelated gene expressional plasticity.
Introduction
Interactions of the cell and microenvironment involve integrin-mediated co-activation of receptor kinases without the participation of relevant parental growth factor receptor ligands (Comoglio et al., 2003) . The resultant crosstalk signaling can be categorized as collaborative, integrin-dependent activation of growth factor and growth factor-dependent activation of integrin signaling processes. These adhesion-independent engagements result in multiple, parallel activities that are organized into signaling networks, supporting the physiologically relevant responses to microenvironmental cues.
Transforming growth factor-b (TGF-b) signaling controls cell proliferation, differentiation and cell death, depending on cell type and the microenvironment (Chen et al., 1998; Dumont and Arteaga, 2002; Feng and Derynck, 2005; Hoodless and Wrana, 1998; Massague, 2000; Piek et al., 1999a, b; Segarini, 1990) . The canonical TGF-b pathway is initiated by ligandinduced heterotetramer types I and II serine-threonine kinase receptor complexes (Huse et al., 1999; Wrana et al., 1992 Wrana et al., , 1994 Groppe et al., 2008 ). The activated receptor complex then phosphorylates the receptorregulated Smad 2 and 3 (R-Smads) at the COOHterminal region presented by SARA (Tsukazaki et al., 1998) . R-Smad activation requires endocytosis (Garamszegi et al., 2001; Penheiter et al., 2002; Di Guglielmo et al., 2003) . R-Smads then complex with Smad4 and are transported into the nucleus, in which they regulate transcription (Attisano and Wrana, 2002) . TGF-b receptor signaling dynamics also incorporate Smadindependent mechanisms (Derynck and Zhang, 2003; Moustakas and Heldin, 2005; Zhang, 2009) .
A TGF-b pathway-propagated Smad signaling is known to be induced by integrin aVb6-and aVb8-dependent mechanisms. These interactions engage the inactive (chelated) TGF-b isoforms by latency-associated protein and latent TGF-b binding protein complexes (Mu et al., 2002; Munger et al., 1999) . Importantly, all previously reported mechanisms require the native TGF-b ligands to initiate the signaling cascade.
Interaction between TGF-b and collagen signaling has been described previously (Qi and Scully, 1997 , 2000 , and limited synergism between collagen and Smad signaling has been reported (Lee et al., 2005; Schneiderbauer et al., 2004) . To date, it was unknown whether this could be applicable to other matrix molecules and the role of participating receptors and TGF-b ligand requirement was not clarified. This paper shows that Smad activation by soluble extracellular matrix (ECM) peptides does not require native TGF-b ligand participation. It describes a novel interaction between active integrin signaling components and functional TGF-b receptors that lead to a distinct gene expressional profile. The data support an extended TGF-b receptor activity scenario in which ECM-induced responses are integrated into the existing signaling networks. These data contribute to and partially explain the reasons for the enormous complexity of TGF-b receptor activity under normal and pathological conditions.
Results

Soluble ECM peptides activate Smad phosphorylation
Western blotting shows that TGF-b1 exposure induces marked Smad2 and 3 phosphorylation within 15 min . Type II collagen (CII) exposure resulted in a significant but lower magnitude Smad phosphorylation with similar kinetics and R-Smad specificity. Collagen induction of H357, MCF-7 and Mv1Lu cells (Figures 1a, b and e) generates weaker Smad2 activation than in C28 or JJ012 (Figures 1c and d ). This activation is observed with other matrix molecules, in which the extent of Smad activation parallels the affinity of the a2b1 integrin for these targets (Supplementary Figure  S1) . The downstream events after this activation were further analyzed using fluorescent microscopy, indicating that both CII and TGF-b1 exposure resulted in Smad4 nuclear accumulation (Figure 1f ). This activation is specific to ALK4, 5 and 7 receptors (processing Smad2 and 3), as Smad1, 5 and 8 (R-Smads to bone morphogenetic protein (BMP) receptors) are not activated similarly by ECM peptides (Figure 1g ).
The crosstalk signaling and its consequences depend on both TbR1 and TbR2 receptors To verify ALK5 receptor involvement, the A-83-01 inhibitor was used to evaluate crosstalk signaling (Figure 2a ). The results show that A-83-01 affects both the collagen and TGF-b1-induced processes equally, indicating the importance of ALK5 for both signaling pathways. To understand the role of TGF-b receptors in this process, Mv1Lu spontaneous mutant cell lines were used (R1B (TbR1) and DR26 (TbR2); Laiho and KeskiOja, 1992; Laiho et al., 1991) . Figure 2b shows that TGF-b1 and collagen stimulate Smad phosphorylation in parental Mv1Lu cells. In contrast, neither TGF-b1 nor collagen induces Smad activation in either of the mutant cell lines, suggesting that both TbR1 and TbR2 receptors are required.
To identify a crosstalk signaling functional consequence and its dependence on TbR1 activity, the CII effect on cell migration was measured in a woundhealing assay ( ± A-83-01 inhibitor, Figure 2c ). The results show that the inhibitor alone does not affect cell migration (*P ¼ 0.936). CII exposure increases migration significantly (**P ¼ 0.0305), and this increase can be specifically eliminated by A-83-01. To show that the pathway is activated, Smad4 nuclear translocation was detected using fluorescence microscopy ( Figure 2d) . The results show boundary cell signaling through turquoise color shift of 4,6-diamidino-2-phenylindole (blue)-counterstained nuclei as a consequence of Smad4 (green) nuclear translocation by CII. This color shift can be prevented by the A-83-01 inhibitor.
Native TGF-b ligand is not required for ECM peptideinduced Smad activation The involvement of TGF-b ligand in crosstalk signaling was analyzed through four complimentary approaches. First, a scavenging antibody (AB-100-NA) was used to remove either autocrine or contaminating TGF-b (Figure 3a) . The antibody attenuates Smad activation in response to TGF-b1 (Po0.0001, Figure 3c ) but does not have any effect on collagen response (P ¼ 0.1078 at 30À/30 þ , P ¼ 0.0112 at 60À/60 þ and P ¼ 0.0095 at 90À/90 þ ). Second, to evaluate the possibility of the matrix peptide samples' TGF-b contamination, MAL-DI-TOF-MS analysis of the matrix samples are presented (Supplementary Figure S2) , showing that no TGF-b isoform contaminations can be observed. Third, the reintroduction of the wild-type TbR2 receptor (ZnCl 2 -inducible construct on a DR26-and TbR2-negative background) facilitates Smad activation by both TGF-b1 and collagen with the same characteristics as observed in previous experiments (Figure 3b ). In contrast, the analysis of DR26D25 mutant TGF-b type II receptor reintroduction (Groppe et al., 2008) shows that this mutation facilitates only the collagen-induced signal propagation but not the TGF-b1-induced process (Figure 3b ). Densitometry indicates that TGF-b1-induced Smad activation is not significantly different from that of untreated control (P ¼ 0.7149, Figure 3d ). This is in sharp contrast to collagen induction of Smad activation with the D25 construct, which shows normal kinetics (P ¼ 0.0006). The Zn þ þ induction efficiency of wild-type and D25 mutant constructs is presented in Supplementary Figure S3 . Fourth, the existence of collagen-induced Smad response in H357 cells ( Figure 1a ) indirectly verifies its independence from aVb6 and aVb8 integrin-mediated latent TGF-b binding protein and latency-associated protein-contributed TGF-b pathway activation, because H357 has no detectable aV receptor (Jones et al., 1996) . These approaches show that TGF-b ligand involvement is not required for ECM-induced crosstalk activity to occur.
The crosstalk process requires functional integrin receptors
To determine the role of the collagen receptor (a2b1 integrin (VLA-2)) in Smad activation, a blocking antibody (MMS-488R) was used to compete with collagen binding (Figure 4a ). This antibody affected only the CII-induced Smad activation. To extend these findings, RNA interference (RNAi) was used to stably knockdown the integrin b1 receptor (Supplementary Figures S4b) . Two clones with significant integrin b1 mRNA reduction (T 53 ¼ 88% decrease, and T 54 ¼ 91% decrease) were selected for further analysis. The specificity of the RNAi effect was verified through integrin b2, b8 and aV receptors, which were minimally altered (Supplementary Figure S4b) . The RNAi knockdown of the integrin b1 result was verified at the protein level using western blotting (Figure 4b ). The analysis of Smad activation in the parental cells, scrambled vector control and two transfected clones is depicted in Figure 4c . The results are notable for the fact that only collagen-induced Smad activation is sensitive to integrin b1 elimination (T 53 and T 54 ) . The TGF-b1 response is unaffected, indicating that the mechanism underlying Smad activation by these ligands is inherently different.
To determine whether collagen-induced Smad activation involves the integrin signaling cascade, PP2 (4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo [3,4-d] pyrimidine), an inhibitor of Src and focal adhesion kinase (FAK) activity was used (Figures 4d and e) . At each time point, PP2 is able to blunt collagen-induced Smad activation, but had no discernable effect on TGF-b-induced Smad activation (Figure 4d ). The efficacy of PP2 in blocking Src activity was confirmed by the inhibition of pY578FAK phosphorylation, which is present under both conditions of collagen and TGF-b exposure (Figure 4e ). Although collagen-induced Smad activation was decreased by Src inhibition (verified through pY576 ) were plated to immediate confluency and synchronized overnight in serum-free media before exposure to any treatments. Mesenchymal (C28, JJ012, H357) and endo-/epithelial (MCF-7, Mv1Lu) cells were studied. Smad activation (pSmad) kinetics was analyzed. (f) Smad4 nuclear translocation was detected with immunofluorescence after 1 h incubation with type II collagen ( þ CII) and TGF-b1 exposure. JJ012 cells were imaged on a Zeiss Axio II microscope at Â 40 power. (g) The pathway specificity of the ECM-induced process was analyzed through Smad1, 5 and 8 analyses (BMP signaling pathway). It is clear that within the same time frame as in (a-e), no parallel activation of BMP signaling is observed by collagen when compared with BMP2 ligand (355-BEC/CF; R&D). Characteristic signaling responses for phospho-Smad1, 5 and 8 were detected by antibodies from Cell Signaling Technology (9511s) and Santa Cruz (sc-6031-R). All experiments were repeated three times. A full colour version of this figure is available at the Oncogene journal online.
Smad activation by extracellular matrix peptides N Garamszegi et al FAK phosphorylation), TGF-b1-stimulated Smad activation was unaffected. It should be noted that, whereas 100 nM PP2 is sufficient and specific for inhibition of crosstalk signaling only, a larger dosage (B10 mM) also affects the TGF-b pathway through unspecific inhibition (data not shown). The presented data in Figures 1-4 support the hypothesis of a novel interaction between integrin a2b1 complex and TbR1 and TbR2 receptors.
The crosstalk process represents a novel interaction between integrin and TbR1 and 2 receptors To further assess the possibility of interactions at the receptor level, co-immunoprecipitation (co-IP) experiments were performed ( Figure 5a ). Western blotting was used to detect: (1) target proteins from cell lysates, (2) proteins precipitated with nonrelated green fluorescent protein (GFP) antibody control, (3) VLA-2 (a2b1)-precipitated proteins, (4) VLA-2 pull-down of integrin b1 antibody with epitope competition and (5) The necessity of TGF-b receptors is further confirmed using Mv1Lu and its native mutant derivatives R1B and DR26 cell lines (Laiho et al., 1991) . No activation was observed either in R1B or DR26 cells at any time point analyzed. (c) The confluent C28 cells (six-well plates 0.5 Â 10 6 cells/well) were synchronized overnight, and wounded with a sterile 200 ml pipette tip. Wound distances (mM) were measured at defined nine points (three parallel marker lines crossed by three parallel wounds) at indicated times. The results are plotted as percentage of the open wound area, starting at 0 h (100%). The controls (no treatment (NT)), in combination with inhibitor A-83-01 (A83/NT) alone , and together with inhibited CII treatments (A83/CII), show no significant difference from each other (analysis of variance (ANOVA), *P ¼ 0.936). CII treatment shows accelerated wound closure (ANOVA **P ¼ 0.0305). (d) Smad4 nuclear translocation of C28 cells. Parallel plates were fixed and stained with Rhodamine-Phalloidin (red, stress fibers), Smad4 (green) and DAPI (blue, nuclear counter stain). The pathway activity is indicated by the turquoise color shift of the nucleus (no inhibitor), which is prevented by the inhibitor A-83-01 (larger magnification). Bar ¼ 100 mM. A full colour version of this figure is available at the Oncogene journal online. 
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Figure 3 TGF-b ligand independence of collagen-induced Smad activation. (a) Plates were pre-incubated for 2½ with the scavenging AB-100-NA antibody ( þ 25 mg/ml) to allow for sequestering the endogenously produced/externally added TGF-b1 ligand. This preincubation does not diminish collagen-induced Smad activation at any time point (pSmad2 lane at CII treatment AB-100-NA þ parallel samples). Positive control; 1.0 ng/ml TGF-b1 ligand was used to induce pSmad2 in untreated (À) and AB-100-NA pretreated plates. (b) DR26 wild-type (WT) and DR26D25 mutant cells were plated to immediate confluency (5.0 Â 10 6 cells/100 plates) and synchronized overnight, followed by 40 mM ZnCl 2 induction for WT and D25 TGF-b type II receptor production (24 h, Supplementary Figure S3 ) as described (Groppe et al., 2008) . After induction, the cells were exposed to type II collagen (CII, 50.0 mg/ml) and TGF-b1 (1.0 ng/ml) treatments to analyze Smad2 activation at indicated time points. Only the TGF-b1 treatment is blocked by the mutant. (c) Quantization of phospho-Smad2 values shows that AB-100-NA treatment was significantly different for TGF-b1 pairwise samples (Po0.0001), whereas parallel samples of collagen induction are basically the same (P ¼ 0.3738). (d) This analysis confirms that the D25 mutant affects the classical TGF-b pathway (Po0.00001 vs P ¼ 0.7149). Collagen (CII) induction generates similar Smad2 phosphorylation (P ¼ 0.0006) as it was observed before or with the parallel experimental control in DR26 WT (P ¼ 0.0009). Here, both pathways produce the characteristic activation profiles (Po0.00001 for TGF-b1). The ZnCL 2 induction itself was controlled on untransformed DR26 CTRL (Supplementary Figure S3) . These results prompted us to analyze whether the signaling complex formation could be related to the cell surface contact points that were induced by collagen exposure (Figure 5b ). To evaluate this, cell surface immunofluorescent staining was used to localize TbR1 (green) and integrin b1 (red). The initial staining of receptors was followed by cell permeabilization and Vinculin (blue) staining (a marker of adhesion structures and focal adhesion points). These cells show the surface membrane domains as dotted structures in the absence of mechanical stress. These are evident in the isolated red staining only (integrin b1). Smaller surface populations are labeled as yellow (integrin b1 þ TbR1), indicating that the targeted receptors occupy the same domain, and a few of them are detected as white (integrin b1 þ TbR1 þ Vinculin). The higher magnification shows only a partial overlap with Vinculin staining.
Collagen-induced activation generates distinct gene expressional patterns
The specific transcriptional response to collagen binding was evaluated using a TGF-b/BMP-specific pathway array and was confirmed using quantitative PCR (Supplementary Figures S5a-d and Supplementary  Table S1 ). In chondrocytes (C28 cells), collagen exposure resulted in only a significant upregulation of a subset of genes activated by TGF-b, including EVI1, IGF1 and NODAL (Supplementary Figure S5a) . Interestingly, the classical TGF-b1 responsive genes are not upregulated by collagen exposure (including SER-PINE1, BMP6, JUNB and PDGFB) (Supplementary Figure S5b) . Growth differentiation factors 2 and 6 show collagen selectivity from this set. In comparison, the expressional responses of MCF-10A cells were dramatically different (Supplementary Figure S5c) . Collagen exposure led to no detectable gene upregulation, and there was a borderline downregulation of ID1, ID2 and BMP5. This is in sharp contrast to TGF-b1 results, which elicit a more dynamic activation profile, including the upregulation of SERPINE1, BMP6, SOX4 and FST (Supplementary Figure S5d) . The results indicate that collagen elicits a transcriptional response that minimally overlaps with TGF-b1-generated changes. Moreover, the patterns show cell-type specificity (C28 vs MCF-10A). These transcriptional characteristics further support the contention that the observed mechanism cannot be explained by TGF-b ligand involvement, neither by contamination nor through integrin-mediated autocrine TGF-b1 activation.
The crosstalk signaling-specific gene expressional responses can be recognized on the basis of their ECM induction being reversed by A-83-01. Further analysis of selected inflammation-specific gene signatures shows increased sensitivity to crosstalk signaling (Figure 6a) . Although all genes respond with expressional downregulation for CII or TGF-b1 treatments, collagen elicits stronger responses that are completely reversed by A-83-01 before incubation. Contrary to this observation, TGF-b1 responses are significantly smaller in magnitude and not sensitive to the inhibitor.
Discussion
The complexity of TGF-b signaling reflects a very dynamic receptor biology and diverse functional activity. Previous reports showed limited synergy between collagen peptide-induced and TGF-b signal pathway activation (Schneiderbauer et al., 2004) . The investigation suggested that TGF-b and collagen pathways are incorporated into a wider network and both ligands are required. It was unknown whether Smad activation also occurred in response to binding of other ECM molecules. Questions regarding the role of receptors and specific gene expressional profiles remained unanswered, most importantly including the necessity of native TGFb ligand. TGF-b has been shown to activate both Smaddependent and -independent pathways. Our findings significantly extend previous observations and show that ECM molecules, including fibronectin, collagen and laminin, can activate Smad2 and 3. In the current experimental approach, a soluble matrix peptide was used to enable synchronization of cellular responses to ligand exposure and thus avoid the heterogeneous nature of cell adhesion to a coated substrate. This is intended to mimic cell-matrix interactions with conditions related to matrix remodeling, degradation and invasion. The subsequent studies with collagen as an ECM representative molecule indicate that this response likely represents a common path by which nonattached matrix peptides can interact with cells to influence gene plasticity and their behavior.
The fact that TGF-b ligand contribution to this event is not required is supported by the following eight complementary experimental observations: (1) Possible contaminating TGF-b is below detectable levels in ligand preparations, as determined using MALDI-TOF-MS (Supplementary Figure S2) . (2) Antibody scavenging of TGF-b was able to attenuate only TGFb1 responses but not collagen inductions (Figure 3a (Figure 1a) . (7) Upregulation of the aV receptor does not rescue integrin b1 knockdown (Figure 4c and Supplementary Figure 4) . All previously known integrin-dependent TGF-b pathway activation processes require ligand involvement, and the mechanism is fundamentally different than that involving latent TGF-b binding protein and latency-associated protein complexes (Gupta et al., 2007; Kracklauer et al., 2003; Sheppard, 2004) . The existence of matrix peptide-induced Smad activation in H357 cells excludes an aV integrin-dependent mechanism as a possible explanation for crosstalk activation. (8) Activation by collagen results in a transcriptional response that is distinct from TGF-b (Supplementary Figure S5) . Figure S4a) . It also shows that R1B cells express a TbR1 protein, but this has been shown to be nonfunctional (Laiho et al., 1991) . DR26 cells do not have functional TbR2 receptors and therefore cannot trans-phosphorylate TbR1, which renders the pathway inactive (Boyd and Massague, 1989; Laiho and Keski-Oja, 1992; Laiho et al., 1990 Laiho et al., , 1991 . Integrin b1 and TbR1 receptors can coexist and their recruitment can be further induced by collagen binding to the same membrane domains, as determined using immunofluorescence and co-IP. The colocalization of some of these complexes with Vinculin indicates selective signaling recruitment within the plasma membrane at sites of nascent ligand receptor interactions with the ECM (Evans and Matsudaira, 2006; Franz and Muller, 2005; Gonzales et al., 2001; Parsons et al., 1994; Petit and Thiery, 2000; Ziegler et al., 2006) . The novel observation is that TGF-b receptors can also be incorporated into these domains. Cell attachment through integrins and subsequent signaling requires Src and FAK activity (Madan et al., 2006) . In this study, we showed that Src activity is required for collageninduced Smad activation but not for the TGF-b1-generated signaling process. This result supports the notion that Src could be required for crosstalk signal propagation. FAK and Src were also present in the immunoprecipitated complex. These observations suggest that the proposed receptor complex could exist preformed in the same membrane domain, and/or its recruitments can be induced on soluble ECM ligand/ integrin receptor interactions. Previous analysis of the DR26D25 TGF-b type II receptor mutant shows that this mutant is defective in the recruitment of TbR1 receptor for signaling through TGF-b1/TbR2 binding and therefore prevents the ligand-induced, activated TGF-b receptor heterotetramer complex cooperative assembly (Groppe et al., 2008) . The observation that the TbR2 DR26D25 mutation does not block the ECMinduced process (Figure 3b ) supports the fact that the crosstalk (1) does not require TGF-b ligand and (2) the TGF-b receptor complex required is at least a heterodimer (TbR1xTbR2; Figures 2b and 5a) . Early crosslinking studies verified the existence of monomer, homodimer, heterodimer, heterotetramer and larger-order complexes at the plasma membrane (Yamashita et al., 1994) . More recently, fluorescence recovery after photobleaching experiments identified the TbR1 and TbR2 receptor domains that are required for homodimerization and hetero-oligomerization. All forms of homo-and hetero-oligomers were constitutively present on the plasma membrane (Rechtman et al., 2009) . The observed lower magnitude of collagen-induced Smad activation can be explained by postulating that the ECM-induced process only involves the heterodimer TGF-b receptor. This may already result in lower signal processing capacity. This prediction can be validated by future stochiometric and crystallographic studies of detailed complex assembly.
The kinase inhibitor A-83-01 indicates the importance of ALK5 for both processes (Tojo et al., 2005) . The experiments using R1B and DR26 cells with impaired TGF-b receptor functions show that the mechanism requires both kinases to function. This is consistent with the observation that only TbR1 has been shown to be capable of activating Smad2 and 3 molecules (Wrana et al., 1992) . The inhibitor also provides an opportunity to separate crosstalk signaling-dependent gene expressional patterns (Figure 6a and Supplementary Figure  S5 ) from the canonical TGF-b responses. One should expect that if the crosstalk process uses TGF-b pathway components for signal propagation, TGF-b ligand responsive genes would be activated. The use of the BMP/TGF-b pathway-specific superarray clarifies that CII-induced responses minimally overlap with TGF-b1-induced changes, and the patterns are cell type and condition dependent (that is, the same array shows different patterns by cell type and normal vs cancer). TGF-b and collagen are capable of promoting chondrocyte differentiation, which has been reported and attributed to independent linear pathways (Benya et al., 1978; Benya and Shaffer, 1982; Galera et al., 1992; Hill and Logan, 1992; Rosier et al., 1989; Suzuki, 1992; Thorp et al., 1992) . The current results show that soluble ECM effects incorporate partial TGF-b receptor dynamics, and because collagen-induced gene expressional responses are distinct from TGF-b ligand-induced signaling, it suggests a unique role in cell-matrix interaction.
One of the functional consequences of crosstalk signaling is showed by the CII effect on C28 cell migration in a wound-healing assay (Figures 2c-d) . Collagen exposure increases the migration and repopulation of the wounded surface. This effect cannot be explained by the guidance based on the filamentous shape of CII because it can be blocked by A-083-01, indicating Smad activation by extracellular matrix peptides N Garamszegi et al crosstalk signaling involvement. The Smad4 nuclear translocation of boundary cell layers (Figure 2d ) further confirms this result. Furthermore, laminin exposure (which similarly induces crosstalk signaling, Supplementary Figure S1 ) inhibits wound surface repopulation significantly (not shown). The A-83-01 inhibition effect (for gene expressional and functional consequences) blocking activated TbR1 receptor signal propagation activity through its ATP binding site is equivalent to effects achievable by TbR1 RNAi, dominant-negative expression and/or double knockdown of Smad2 and 3.
Signaling model
We propose a model to summarize what is known about this signaling mechanism (Figure 6b ). On collagen binding to integrin a2b1 (left-hand side), integrin signaling is initiated by a2b1 cytoplasmic domain changes and Src, FAK incorporation to the complex. If the collagen is 'soluble' and not cross-linked extensively to ECM, parallel crosstalk signaling initiation occurs (Figure 6b , right-hand side) by recruitment of TGF-b receptors to the same nascent receptor-ligand interaction site. A-83-01 inhibitor cannot block TbR1 receptor activation because its action mechanism is to block the ATP binding site (which is not available before activation) (Huse et al., 1999 (Huse et al., , 2001 . It prevents subsequent signal propagation by rendering the kinase function inactive through this competitive binding. Consequentially, it will block TbR1 signaling activity regardless of which stochiometric complex formation leads to its activation. We speculate that, as native ligand participation is not necessary for crosstalk signaling, high-activity heterotetramer TGF-b receptor complex formation does not occur (Groppe et al., 2008) . We are now better able to understand how the ECM affects gene expression, modifies cellular phenotype and contributes to healthy tissue homeostasis regulation. We suspect that this type of ECM peptide-TGF-b crosstalk signaling connection is one of the many controlling nodes that are present in cells and tissues contributing to expressional gene plasticity.
The described process expands the previously established paradigms by adding an extra dimension to TGFb receptor dynamics in response to general matrix inputs. Our data support the diverse roles of the observed higher-order receptor complexes and ligands in TGF-b receptor biology, and may serve as a basis for improved understanding of the diversity of TGF-b signaling responses.
Materials and methods
Cell culture C28 chondrocyte and JJ012 and 105KC human chondrosarcoma cell lines were cultured in Dulbecco's modied Eagle's medium, F12, minimum essential medium-a and fetal bovine Table S1 summarizes the description of genes analyzed. The inhibitor pretreatments (5.0 mM for 45 min at 37 1C in 5% CO 2 ) are red ( A-83/CII and A-83/TGF-b1), and induction by collagen (CII, ') and native ligand (1.0 ng/ml, TGF-b1, &) is black. The reversal of CII by A-83-01 is highly significant (Po0.00001), whereas TGF-b versus A-83-01/TGF-b does not show any reversibility (P ¼ 0.094). All experiments are repeated on three independent plates and in triplicate. (b) The specific cooperative assembly of high-activity TGF-b receptor heterotetramer complex is indicated by color-coded extracellular domains (only one set for clarity) of receptors and TGF-b1 ligand. The antiparallel orientation of heterodimers is also emphasized by their smaller name tags. The inhibitor of ALK5 is labeled in red and the crosstalk process (right side) is separated by ( ) and symbolized with . The observed limited signal processing capacity of the ECM process is emphasized by the involvement of only one set of TbR heterodimers (as native ligands are not required, a heterotetramer formation is not likely). A full colour version of this figure is available at the Oncogene journal online.
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Cell migration/wound-healing assays Plates were marked by three parallel lines previously seeded to define nine measuring points. Cells were seeded (0.5 Â 10 6 cells/ well) to immediate confluency and synchronized overnight. The experiments were repeated three times. Analysis of variance (null hypothesis ¼ treatments are different) was used to establish the significance of the data set.
Matrix peptides and chemicals
Matrix peptides fibronectin (F4759; Sigma), type I collagen (C9301; Sigma), type II collagen (20022; Chondrex, Redmond, WA, USA) and laminin (L2020; Sigma) were used at 50 mg/ml final concentration. The positive control TGF-b1 was obtained from R&D Systems (Minneapolis, MN, USA) (240-B). 4-Amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo [3,4-d] pyrimidine (PP2, 529576; EMD, San Diego, CA USA) and A-83-01 were purchased from Tocris Bioscience (Ellisville, MO, USA).
Western blotting
Cells were lysed with 50 mM Tris-HCl pH 7.4, 1% NP-40, 0.25% Na-deoxycholate, 150 mM NaCl, 1 mM EDTA, 1 mM Na-vanadate and 1 mM phenylmethylsulfonyl fluoride, as well as with protease inhibitor cocktail obtained from Roche (Indianapolis, IN, USA) (1 Â complete EDTA), and were normalized for protein content. Primary antibodies pSmad2, Smad2 (3101 and 3122; Cell Signaling Technology, Danvers, MA, USA), Smad3 (51-1500; Zymed) and pSmad3 were gifts from Edward B Leof (Mayo Clinic, Rochester, MN, USA). pY576 FAK (44-652-G) and FAK (AHO050) was purchased from BioSource (Invitrogen). Secondary antibodies NA931 and NA934 were from Amersham (GE Healthcare, Piscataway, NJ, USA), and the AB-100-NA TGF-b scavenging antibody was obtained from R&D Systems (Minneapolis, MN, USA). Detection was carried out with SuperSignal West Pico Chemiluminescent Substrate from Pierce Biotechnology (Thermo Scientific, Rockford, IL, USA), and imaged on a UVP Digital Biospectrum system (UVP, Upland, CA, USA).
Stable integrin b1 downregulation by RNAi
The Origene (TR320392; Rockville, MD, USA) HuSH 29mer shRNA kit (Locus ID 3688) providing vector control and four target variants was used to downregulate integrin b1 receptor in JJ012 chondrosarcoma cells. The cells were transfected by FuGENE HD (Roche) and the clones were isolated by puromycin (P9620; Sigma) selection.
Co-Immunoprecipitation
Integrin aggregation was induced by type II collagen pretreatments (50.0 mg/ml at room temperature) for 25 min. The VLA-2 (a2b1) antibody (MAB 1998; Chemicon) was used to immunoprecipitate the molecular complexes. Integrin b1 antibody preincubation (MAB 1965 or MAB 1968 for 25 min at 25.0 mg/ml; Chemicon, Temecula, CA, USA) was used in IP competition experiments on selected plates. The a2b1 receptors were precipitated overnight at 4 1C. The GFP antibody (sc-9996; Santa Cruz, Santa Cruz, CA, USA) was used as nonspecific antibody control (cell lines do not express GFP). Integrin b1 was precipitated with Santa Cruz sc-9970 antibody with 45-60 ml protein A agarose (P7786; Sigma) or anti-mouse IgG (A6531; Sigma). IP fractions were separated using 8.0 and 10.0% sodium dodecyl sulfate-polyacrylamide gel electrophoresis. TbR1, TbR2, integrin a2, integrin b1 and cellular Src FAK GFP were then detected using western blotting with antibodies from Santa Cruz (sc-339, sc-220, sc-9089, sc-8978, sc-19, sc-558 and sc-8334) or FAK-specific BioSource (AHO0502).
Immunostaining
The cells were cultured in four-chamber slides (Labtek no. 177399; NUNC International, Rochester, NY, USA) after treatment with 4% formaldehyde/phosphate-buffered saline. The primary antibodies used were integrin b1 (MAB1965; Chemicon), TbRI (sc-9048; Santa Cruz), Vinculin (sc-7649; Santa Cruz) and Smad4 (06-693; Upstate, Lake Placid, NY, USA). The secondary antibodies used were Alexa F350, A21081 blue; Alexa F488, A21441 green; and Alexa F594, A 21201 red (Molecular Probes, Eugene, OR, USA). Slides were mounted with ProLong antifade solution (P-7481; Molecular Probes). Imaging was carried out using a Zeiss LSM510 confocal microscope (Carl Zeiss, Thornwood, NY, USA) (University of Miami Sylvester Comprehensive Cancer Center, Bioimaging Core).
